Pharmacological inhibition of the ERK/STAT3 axis with selumetinib or static or the Gpr132 protein hampered lactate-induced M2 macrophage polarization and showed significant anti-tumor effects in preclinical studies (278, 279) (Figure 1C). Here, STAT3 is linked to neoplasm.